Literature DB >> 6421159

Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis.

C L Mendenhall, S Anderson, R E Weesner, S J Goldberg, K A Crolic.   

Abstract

Three hundred sixty-three alcoholic patients with alcoholic hepatitis were studied in six Veterans Administration medical centers. By history, alcohol consumption was 227.9 g per day, with a mean duration of 23.8 years. Cirrhosis accompanied the alcoholic hepatitis in 58.7 percent of the patients who underwent biopsy or autopsy. Complete nutritional assessment was performed in 284 patients, and observed nutritional changes were classified into those associated with marasmus or those characterizing kwashiorkor. A smaller comparison group of 21 alcoholic patients matched for age and alcohol consumption but without clinically evident liver disease was also studied in an identical manner. None of the patients with liver disease was completely free from malnutrition, whereas 62 percent of the alcoholic patients without liver disease showed abnormalities. In patients with alcoholic hepatitis, some findings associated with marasmus were seen in 86 percent, and some features of kwashiorkor were observed in 100 percent. When present together, the complete picture of kwashiorkor and marasmus correlated closely with the clinical severity of the liver disease (p less than 0.005). The nearly constant association of either complete or partial kwashiorkor or marasmus suggests that the separation of these two entities is artificial in alcoholic patients with liver disease. Although, experimentally, malnutrition may not be essential for the development of alcoholic hepatitis, clinically, it appears to precede the development of the liver injury, which suggests an interaction. Recognition is important so that appropriate nutritional therapy can be provided.

Entities:  

Mesh:

Year:  1984        PMID: 6421159     DOI: 10.1016/0002-9343(84)90776-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  67 in total

1.  Alcoholic Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

2.  Protein-calorie malnutrition in liver cirrhosis.

Authors:  H U Lautz; O Selberg; J Körber; M Bürger; M J Müller
Journal:  Clin Investig       Date:  1992-06

Review 3.  Zinc and liver disease.

Authors:  Mohammad K Mohammad; Mohammad K Mohommad; Zhanxiang Zhou; Matthew Cave; Ashutosh Barve; Craig J McClain
Journal:  Nutr Clin Pract       Date:  2012-02       Impact factor: 3.080

4.  Effects of Clostridium difficile infection in patients with alcoholic hepatitis.

Authors:  Vinay Sundaram; Folasade P May; Vignan Manne; Sammy Saab
Journal:  Clin Gastroenterol Hepatol       Date:  2014-03-27       Impact factor: 11.382

Review 5.  Alcoholic liver disease and malnutrition.

Authors:  Craig J McClain; Shirish S Barve; Ashutosh Barve; Luis Marsano
Journal:  Alcohol Clin Exp Res       Date:  2011-02-01       Impact factor: 3.455

6.  Activated CD-8 cells and HLA DR expression in alcoholics without overt liver disease.

Authors:  R T Cook; M J Garvey; B M Booth; J A Goeken; B Stewart; M Noel
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

Review 7.  Conceptual importance of identifying alcoholic liver disease as a lifestyle disease.

Authors:  Hidekazu Tsukamoto
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

Review 8.  Dietary and nutritional indications in hepatic encephalopathy.

Authors:  Manuela Merli; Oliviero Riggio
Journal:  Metab Brain Dis       Date:  2008-12-04       Impact factor: 3.584

Review 9.  Alcoholic liver disease.

Authors:  A D Thomson; G L Bird; J B Saunders
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 10.  Advances in alcoholic liver disease: An update on alcoholic hepatitis.

Authors:  Randy Liang; Andy Liu; Ryan B Perumpail; Robert J Wong; Aijaz Ahmed
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.